Inactive Instrument

Steris PLC Share Price Nyse

Equities

GB00BVVBC028

Medical Equipment, Supplies & Distribution

Sales 2024 * 5.46B 455B Sales 2025 * 5.73B 477B Capitalization 20.15B 1,680B
Net income 2024 * 544M 45.36B Net income 2025 * 641M 53.45B EV / Sales 2024 * 4.23 x
Net Debt 2024 * 2.94B 245B Net Debt 2025 * 2.41B 201B EV / Sales 2025 * 3.94 x
P/E ratio 2024 *
37.2 x
P/E ratio 2025 *
30.2 x
Employees -
Yield 2024 *
1%
Yield 2025 *
1.09%
Free-Float 99.73%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 51 01/18/01
Director of Finance/CFO 56 01/14/01
Investor Relations Contact - 01/04/01
Members of the board TitleAgeSince
Director/Board Member 74 01/08/01
Director/Board Member 74 01/03/01
Director/Board Member 58 28/20/28
More insiders
STERIS plc is one of the world's leading providers of infection control solutions and procedural services. Net sales break down by activity as follows: - sales of infection control solutions (62.9%): including cleaning and sterilization chemicals, accessories for gastrointestinal procedures, washers, sterilizers and operating room equipment (including surgical tables, lighting and connectivity solutions). In addition, the group offers specialized healthcare services (sterilization services, instrument and endoscope repair and maintenance and customized process improvement consulting in acute care hospitals); - development of applied sterilization solutions (22.1%): contract development of sterilization modalities and laboratory testing services for more than 50 sterilization and laboratory facilities worldwide; - manufacturing of consumables and maintenance equipment (15%): dedicated to pharmaceutical manufacturers. Net sales by source of income are divided into sales of services (53.5%), sales of consumables (23.4%) and sales of equipment (23.1%). Net sales are distributed geographically as follows Ireland (2.3%), the United States (71.7%) and other (26%).
Calendar
Related indices
More about the company